Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3754)
All Articles published online
|
Publishing Process of This Article
|
Sep 16, 2021 (publication date) through Nov 20, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Endoscopy
ISSN
1948-5190
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ramsey ML, Sobotka LA, Krishna SG, Hinton A, Kirkby SE, Li SS, Meara MP, Conwell DL, Stanich PP. Outcomes of inpatient cholecystectomy among adults with cystic fibrosis in the United States. World J Gastrointest Endosc 2021; 13(9): 371-381 [PMID: 34630887 DOI: 10.4253/wjge.v13.i9.371] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i9/371.htm |
| Number | Citing Articles |
| 1 |
Marta Solís García, Claudia Madrid Carbajal, Rosa María Girón Moreno. Acute cholecystitis in cystic fibrosis patients after initiation of treatment with elexacaftor/tezacaftor/ivacaftor. Medicina Clínica (English Edition) 2023; 160(11): e5 doi: 10.1016/j.medcle.2023.05.005
|
| 2 |
Catherine M. McDonald, Elizabeth K. Reid, John F. Pohl, Tatiana K. Yuzyuk, Laura M. Padula, Kay Vavrina, Kimberly Altman. Cystic fibrosis and fat malabsorption: Pathophysiology of the cystic fibrosis gastrointestinal tract and the impact of highly effective CFTR modulator therapy. Nutrition in Clinical Practice 2024; 39(S1) doi: 10.1002/ncp.11122
|
| 3 |
Marta Solís García, Claudia Madrid Carbajal, Rosa María Girón Moreno. Colecistitis aguda en pacientes con fibrosis quística tras inicio de tratamiento con elexacaftor/tezacaftor/ivacaftor. Medicina Clínica 2023; 160(11): e5 doi: 10.1016/j.medcli.2023.01.021
|